Understanding SAMD9L-Associated Autoinflammatory Disease (SAAD)
At a Glance
SAMD9L-associated autoinflammatory disease (SAAD) is a rare genetic condition that can cause inflammation without infection and low blood counts. Some children also develop balance or eye-movement problems, and monitoring is tailored to each child because symptoms vary.
Receiving a diagnosis of SAMD9L-associated autoinflammatory disease (SAAD) can feel overwhelming, especially when most doctors you meet have never heard of it. You are likely navigating a “diagnostic odyssey”—a long journey of testing and uncertainty—to find answers for your child [1]. Because this condition was only recently identified, you may find that your family is learning alongside your medical team [2].
A Spectrum of Possibilities
SAMD9L-associated diseases are not one single condition with a predictable path. Instead, they exist on a spectrum—a range of different ways the genetic change can show up in the body. While your child may have been diagnosed with SAAD, it is helpful to understand the three main ways this genetic change typically presents:
- SAMD9L-Associated Autoinflammatory Disease (SAAD): This pattern is characterized by severe inflammation that doesn’t come from an infection (sterile inflammation). Common signs include panniculitis (painful bumps or inflammation of the fat under the skin) and cytopenias (low blood cell counts) [2][1].
- Ataxia-Pancytopenia (ATXPC): This pattern primarily affects the brain and the blood. Children may experience ataxia (trouble with balance and coordination) and nystagmus (involuntary eye movements) alongside low blood counts [3][4].
- Familial Myelodysplastic Syndrome (MDS): In some families, the primary issue is a predisposition to MDS (a group of disorders where the bone marrow doesn’t make enough healthy blood cells). This can sometimes involve a specific genetic change in the blood cells called monosomy 7 [5][6].
It is important to remember that these are clinically distinct phenotypic patterns, though overlap can exist. A child might have symptoms from more than one category, or their symptoms may change over time [1][7].
Understanding the SAMD9L Gene and Inheritance
The SAMD9L gene acts like a natural brake for cell growth [1]. In children with SAAD, a genetic change causes this brake to be “stuck” in the on position. This is called a gain-of-function mutation [1]. Because the brake is always on, certain cells—especially those in the bone marrow and the immune system—cannot grow and divide as they should [8].
SAMD9L pathogenic variants are generally inherited in an autosomal dominant manner, meaning only one copy of the mutated gene from one parent is needed to cause the disorder (though de novo, or new mutations, also occur). Crucially, this gene exhibits variable penetrance, which means that even people with the exact same genetic change (like parents or siblings) may have very different symptoms or no symptoms at all [5][1]. Because of this, it is highly recommended to consult with a genetic counselor. Parental and relative testing can heavily affect medical surveillance, donor selection for a transplant, and family planning.
Why This Diagnosis Is So Rare
If you feel like you are in uncharted territory, it is because you are. The exact incidence is unknown, but it is exceptionally rare. To date, only a limited number of cases of the entire SAMD9L spectrum have been documented in medical literature worldwide [1][9].
For the specific SAAD phenotype, the numbers are even smaller—some studies have focused on groups of as few as six or seven patients at a time [2][10]. Because it is so rare, there is not yet a “standard” treatment plan that applies to everyone. Instead, doctors must tailor care to your child’s specific symptoms and blood work [1].
Navigating the Emotional Toll
The road to a SAAD diagnosis is often exhausting. Families frequently spend years visiting different specialists—hematologists for blood issues, neurologists for balance, and rheumatologists for inflammation—before the genetic cause is found [1][8].
It is normal to feel:
- Isolated: Knowing that your child has a condition that even specialists may need to research.
- Anxious: Dealing with the uncertainty of a “variable” disease where symptoms can shift.
- Overwhelmed: Managing the frequent blood tests, imaging, and specialist appointments required for monitoring [6][4].
Validating these feelings is a crucial part of your child’s care. You are not just managing a genetic condition; you are navigating a complex medical system on behalf of your family. Finding a care team that is willing to collaborate with national experts and listen to your observations as a parent is essential for long-term management [1].
Common questions in this guide
What is SAMD9L-associated autoinflammatory disease?
What symptoms can a child with a SAMD9L condition develop?
What are the main SAMD9L disease patterns?
How is SAMD9L-associated disease inherited?
Why might genetic testing be confirmed with saliva or a skin sample?
How is a child with SAAD monitored?
Is there one standard treatment plan for SAAD?
Get notified when new evidence is published on SAMD9L-associated autoinflammatory syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (10)
- 1
Genetic and clinical spectrum of SAMD9 and SAMD9L syndromes: from variant interpretation to patient management.
Sahoo SS, Erlacher M, Wlodarski MW
Blood 2025; (145(5)):475-485 doi:10.1182/blood.2022017717.
PMID: 39475954 - 2
Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases.
de Jesus AA, Hou Y, Brooks S, et al.
The Journal of clinical investigation 2020; (130(4)):1669-1682.
PMID: 31874111 - 3
Ataxia-pancytopenia syndrome with SAMD9L mutations.
Gorcenco S, Komulainen-Ebrahim J, Nordborg K, et al.
Neurology. Genetics 2017; (3(5)):e183 doi:10.1212/NXG.0000000000000183.
PMID: 28852709 - 4
Assessing Long-Term Neurologic Outcomes in SAMD9L-Related Ataxia-Pancytopenia Syndrome.
Zingariello CD, Chen DH, Raskind WH, et al.
Movement disorders clinical practice 2024; (11(6)):728-733 doi:10.1002/mdc3.14038.
PMID: 38594844 - 5
Constitutional SAMD9L mutations cause familial myelodysplastic syndrome and transient monosomy 7.
Pastor VB, Sahoo SS, Boklan J, et al.
Haematologica 2018; (103(3)):427-437 doi:10.3324/haematol.2017.180778.
PMID: 29217778 - 6
Spontaneous remission and loss of monosomy 7: a window of opportunity for young children with SAMD9L syndrome.
Erlacher M, Andresen F, Sukova M, et al.
Haematologica 2024; (109(2)):422-430 doi:10.3324/haematol.2023.283591.
PMID: 37584291 - 7
Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms.
Tesi B, Davidsson J, Voss M, et al.
Blood 2017; (129(16)):2266-2279 doi:10.1182/blood-2016-10-743302.
PMID: 28202457 - 8
Of gains and losses: SAMD9/SAMD9L and monosomy 7 in myelodysplastic syndrome.
Cammenga J
Experimental hematology 2024; (134()):104217 doi:10.1016/j.exphem.2024.104217.
PMID: 38649131 - 9
Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes.
Sahoo SS, Kozyra EJ, Wlodarski MW
Best practice & research. Clinical haematology 2020; (33(3)):101197 doi:10.1016/j.beha.2020.101197.
PMID: 33038986 - 10
A diffuse, pustular eruption in a neonate: Recognizing SAMD9L-associated autoinflammatory disease (SAAD).
Miller MM, Rowe G, O'Brien K, et al.
Pediatric dermatology 2024; (41(1)):112-114 doi:10.1111/pde.15411.
PMID: 37571861
This overview of SAAD and the SAMD9L disease spectrum is for education only and does not replace medical advice. A pediatric genetics or specialist team should interpret your child’s results and plan monitoring.